ABSTRACT
Background Although studies have examined the association between tobacco and cannabis use in adolescence with subsequent cognitive functioning, study designs are usually not able to distinguish correlation from causation.
Methods Separate patterns of tobacco and cannabis use were derived using longitudinal latent class analysis based on measures assessed on five occasions from age 13 to 18 in a large UK population cohort (ALSPAC). Cognitive functioning measures comprised of working memory, response inhibition, and emotion recognition assessed at 24 years of age. Mendelian randomization was used to examine the possible causal relationship.
Results We found evidence of a relationship between tobacco and cannabis use and diminished cognitive functioning for each of the outcomes in the observational analyses. There was evidence to suggest that late-onset regular tobacco smokers (b=−0.29, 95%CI=−0.45 to −0.13), early-onset regular tobacco smokers (b=−0.45, 95%CI=−0.84 to −0.05), and early-onset regular cannabis users (b=−0.62, 95%CI=−0.93 to −0.31) showed poorer working memory. Early-onset regular tobacco smokers (b=0.18, 95%CI=0.07 to 0.28), and early-onset regular cannabis users (b=0.30, 95%CI=0.08 to 0.52) displayed poorer ability to inhibit responses. Late-onset regular (b=−0.02, 95%CI=−0.03 to −0.00), and early-onset regular tobacco smokers (b=−0.04, 95%CI=−0.08 to −0.01) showed poorer ability to recognise emotions. Mendelian randomization analyses were imprecise and did not provide additional support for the observational results.
Conclusion There was some evidence to suggest that adolescent tobacco and cannabis use were associated with deficits in working memory, response inhibition and emotion recognition. Better powered genetic studies are required to determine whether these associations are causal.
Competing Interest Statement
CS is employed by Cambridge Cognition. MRM is co-director of Jericoe Ltd, which produces software for the assessment and modification of emotion recognition. LM, RW, SS, MF, JH, and MH report no conflicts of interest.
Funding Statement
The work was undertaken with the support of the MRC and Alcohol Research UK (grant number MR/L022206/1). We acknowledge also support from The Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer); a UKCRC Public Health Research Centre of Excellence (joint funding (grant number MR/KO232331/1) from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the Welsh Government and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration); and the NIHR School of Public Health Research. Support was also provided by the UK Medical Research Council Integrative Epidemiology Unit at the University of Bristol (MM_UU_00011/7). LM, RW, SS, and MRM are members of the UK Centre for Tobacco and Alcohol Studies, a UKCRC Public Health Research Centre of Excellence. LM, REW, SS, and MRM are supported by the NIHR Biomedical Research Centre at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol (BRC-1215-20011) and we acknowledge support from NIHR HPRU in Evaluation. The UK Medical Research Council and Wellcome (Grant ref: 102215/2/13/2) and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors and Liam Mahedy and Marcus R. Munafo will serve as guarantors for the contents of this paper. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health and Social Care. GWAS data were generated by Sample Logistics and Genotyping Facilities at Wellcome Sanger Institute and LabCorp (Laboratory Corporation of America) using support from 23andMe. A comprehensive list of grants funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf). We are extremely grateful to all the families who took part in this study, the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Accepted version
Data Availability
We used data from the Avon Longitudinal Study of Parents and Children (ALSPAC), an ongoing population-based study that contains a wide range of phenotypic and environmental measures, genetic information and linkage to health and administrative records.
